Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4287-4292

  Giannini, Romina ^a   Cavallini, Aldo ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Colorectal carcinoma; Coregulators; Estrogen receptor ; Estrogen receptor ; Estrogen receptor related receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; MESSENGER RNA; METASTASIS TUMOR ASSOCIATED 1 LIKE 1 PROTEIN; METASTASIS TUMOR ASSOCIATED PROTEIN 1; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COREPRESSOR; PROTEIN P300; REPRESSOR OF ESTROGEN RECEPTOR ACTIVITY PROTEIN; THYROID HORMONE RECEPTOR ASSOCIATED PROTEIN 220; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE MUCOSA; MALE; NUCLEOTIDE SEQUENCE; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

COLORECTAL NEOPLASMS; GENE EXPRESSION; HUMANS; NEOPLASM STAGING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 27944463521     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M and Gustafsson J A: Mechanism of estrogen action. Physiol Rev 81: 1535-1565, 2001.
2. Di Leo A, Messa C, Cavallini A and Linsalata M: Estrogen and colorectal cancer. Curr Drug Targets-Immune Endocrine Metab Disor 1: 1-12, 2001.
3. Cavallini A, Messa C, Pricci M, Caruso ML, Barone M and Di Leo A: Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer. Dig Dis Sci 47: 2720-2728, 2002.
4. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G and Papavassilou AG: Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39: 1251-1258, 2003.
5. Yi P, Driscoll MD, Huang J, Bhagat S, Hilf R, Bambara RA and Muyan M: The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta. Mol Endocrinol 16: 674-693, 2002.
6. Klinge CM: Estrogen receptor interaction with co-activators and co-repressors. Steroids 65: 227-251, 2000.
7. Baek SH and Rosenfeld MG: Nuclear receptor coregulators: their modification codes and regulatory mechanism by translocation. Biochem Biophys Res Commun 319: 707-714, 2004.
8. Horard B and Vanacker J-M: Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J Mol Endocrinol 31: 349-357, 2003.
9. Giguere V: To ERR in estrogen pathway. Trends Endocrinol Metab 13: 220-225, 2002.
10. Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R and Bieche I: Expression analysis of estrogen receptor α coregulators in breast carcinoma: evidence that NcoR1 expression is predictive of the response to tamoxifen. Clin Cancer Res 9: 1259-1266, 2003.
11. Vienonen A, Miettinen S, Blauer M, Martikainen PM, Tomas E, Heinonen PK and Ylikomi T: Expression of nuclear receptors and cofactors in human endometrium and myometrium. J Soc Gynecol Investig 11: 104-112, 2004.
12. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S and Sonoo H: Expression levels of estrogen receptor-α, estrogen receptor-β, coactivators, and corepressors in breast cancer. Clin Cancer Res 6: 512-518, 2000.
13. Toh Y, Oki E, Oda S, Tokunaga E, Ohno S, Maehara Y, Nicolson GL and Sugimachi K: Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74: 459-463, 1997.
14. Shang Y, Hu X, DiRenzo J, Lazar MA and Brown M: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852, 2000.
15. Cavallini A, Notarnicola M, Giannini R, Montemurro S, Lorusso D, Visconti A, Minervini F and Caruso MG: Oestrogen receptor-related receptor alpha (ERRα) and oestrogen receptors (ERα and ERβ) exhibit different gene expression in human colorectal tumour progression. Eur J Cancer 41: 1487-1494, 2005.
16. Kawai H, Li H, Avraham S, Jiang S and Avraham HK: Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int J Cancer 107: 353-358, 2003.
17. Huang BH, Laban M, Leung CH, Lee L, Lee CK, Salto-Tellez M, Raju GC and Hooi SC: Inhibition of histone deacetylase 2 increases apoptosis and p21(Cip1/WAF1) expression, independent of histone deacetylase 1. Cell Death Differ 12: 395-404, 2005.
18. Cheung E, Schwabish MA and Kraus WL: Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors α and β. EMBO J 22: 600-611, 2003.